Core Viewpoint - Yangtze River Pharmaceutical Group's subsidiary acquired the Beijing Shimao Building for 2.254 billion yuan, significantly below its appraised value of 3.22 billion yuan, indicating a strategic investment opportunity in the real estate sector [1] Group 1: Acquisition Details - The property auctioned includes a commercial building with a total construction area of 70,174 square meters located in Chaoyang District, Beijing [1] - The starting price for the auction was set at 2.254 billion yuan, and the final transaction price represented a 30% discount from the appraised value [1] Group 2: Company Background - Beijing Yangtze River Real Estate Co., Ltd. is a wholly-owned subsidiary of Yangtze River (Guangdong Hengqin) Health Investment Co., Ltd., which is fully owned by Yangtze River Pharmaceutical Group [1]
扬子江药业旗下企业出手 22.54亿元拍下北京世茂大厦